Medicine at Risk: The National Se...

Medicine at Risk: The National Security Threat in America’s Drug Supply Chain

Deep Dive Dispatch di With John Matthews and Sarah Collins
S1 · E8
22 nov 2024
18:05

Note sull'episodio

Can America’s reliance on foreign pharmaceutical manufacturing jeopardize its health and security?

On this episode of 'Deep Dive Dispatch,' we uncover the hidden vulnerabilities in the U.S. drug supply chain, from supply disruptions to geopolitical risks.

Discover how over-dependence on China and India could spell trouble and explore the government’s efforts—like Executive Order 13944—to secure essential medicines.

With expert insights on domestic manufacturing, transparency, and the Strategic National Stockpile, we’ll reveal what’s at stake and how to build a safer, more resilient system.

Tune in to learn why securing our medicine isn’t just a health issue—it’s a matter of survival.

Parole chiave

Agenda 47
Trump
US Pharmaceutical Supply Chain
Medicine Security
National Security Risks
Drug Supply Vulnerability
Pharmaceutical Manufacturing
Foreign Dependency
Active Pharmaceutical Ingredients (API)
Supply Chain Disruptions
Strategic National Stockpile
Executive Order 13944
Domestic Drug Production
Public Health Policy
Geopolitical Impact on Medicine
Pharmaceutical Imports
Government Initiatives
Drug Transparency
Resilient Healthcare Systems
China and India Pharma Dependency
Healthcare Security